What happened with UFPT today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Medical-device manufacturers hire UFP Technologies to turn their specifications into finished products and components. Its engineers work with customers on design, then the company manufactures items such as robotic-surgery drapes, wound-care products and medical-device packaging. Medical customers provide the vast majority of revenue, and product sales bring in far more than engineering services or tooling and machinery.
Intuitive Surgical SARL and Stryker Corporation are its largest customers and together account for a substantial share of sales, making their orders especially important. Production also depends on outside material suppliers: UFP does not make its own raw materials and relies on a limited number of suppliers for certain specialized foams and thermoplastic urethane.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
UFP Technologies depends heavily on Intuitive Surgical’s purchases of its medical products: Intuitive Surgical SARL accounted for 24.3% of UFP’s 2025 net sales. Intuitive Surgical supports hospitals’ da Vinci surgery and Ion bronchoscopy programs, making procedure growth a useful demand signal to watch.
Stryker’s purchases of UFP Technologies’ medical products accounted for 21.5% of UFP’s 2025 net sales, so its purchasing demand matters directly to UFP’s revenue. Stryker sells medical and surgical, neurotechnology and orthopaedic products; its orders from UFP are the key link to watch.
Nordson competes for business from medical-device manufacturers that pay UFP Technologies for custom components and manufacturing services. Nordson’s medical business supplies engineered tubing, balloons and other device components to these same buyers.
Teleflex competes with UFP Technologies for medical-device manufacturers’ outsourced work. Its business making specialized medical components and devices for those manufacturers overlaps with UFP’s paid development and manufacturing services.
Solventum competes with UFP Technologies for medical manufacturers’ spending on materials and components used in wound care, infection prevention and medical devices. Watch Solventum’s business supplying other manufacturers within MedSurg, rather than its dental products or healthcare software, for this competitive overlap.
Intuitive Surgical Inc. earningsISRG
Intuitive Surgical’s report will show how demand for da Vinci and Ion procedures is changing, a signal for its purchases of medical products from UFP Technologies.
Look for procedure-volume or demand indicators for da Vinci surgery and Ion bronchoscopy, alongside Intuitive Surgical’s explanation of program growth. Stronger demand would mean more hospital use of these systems, supporting a need for related products sourced from UFP; weaker demand would put pressure on a major source of UFP’s sales. Procedures are not purchase orders, so the conclusion is whether the demand signal supports continued Intuitive purchases from UFP.
Fed Interest Rate Decision
The Fed’s decision on short-term interest rates matters to UFP Technologies because rates can change the interest it pays on borrowings tied to SOFR or prime, leaving less or more cash for operations and investment.
Expected4.0%Last release4.0%
If it comes in above expectations
Higher rates can raise the interest UFP Technologies pays as its variable-rate debt reprices, leaving less cash for manufacturing capacity and other investment.
If it comes in below expectations
Lower rates can reduce the interest UFP Technologies pays as its variable-rate debt reprices, leaving more cash for manufacturing capacity and other investment.
Stryker Corporation earningsSYK
Stryker’s report will show demand across its medical and surgical, neurotechnology and orthopaedics businesses, offering a signal about its purchases from UFP Technologies.
Look at sales and demand commentary for Stryker’s medical and surgical, neurotechnology and orthopaedics businesses. Strength there would provide a supportive backdrop for its purchases from UFP; weakness would put this important customer revenue channel under greater pressure. Overall business results do not establish specific purchases, so the conclusion is whether Stryker’s demand supports continued buying from UFP.
Teleflex Incorporated earningsTFX
Teleflex’s report will show medical-device makers’ demand for outsourced components and devices, the same market where UFP Technologies sells development and manufacturing work.
Look at sales and demand commentary for Teleflex’s components and devices sold to medical-device makers. Strength would show manufacturers continuing to spend on these products and suppliers, supporting the market for UFP’s development and manufacturing work; weakness would suggest tighter customer spending and a harder market for outsourced programs. Teleflex’s growth does not mean UFP won orders; the conclusion is whether demand for outsourced supply is expanding or contracting.
UFP Technologies Inc earningsThis company
UFP Technologies develops and makes products for medical-device makers, and its report will show whether sales growth is turning into profit or being eaten up by manufacturing costs.
Read medical-product sales growth alongside gross margin, the share of sales left after direct production costs. Growing sales with a steady or rising margin would show that added customer programs are becoming efficient production rather than being absorbed by costs. Growing sales with a falling margin would show labor, overhead or other production costs taking more from each dollar of product sales. The question is whether UFP can turn medical-business growth into more profit.
